Reduction of infarct volume and apoptosis by grafting of encapsulated basic fibroblast growth factor-secreting cells in a model of middle cerebral artery occlusion in rats

Journal of Neurosurgery

Volumn 99, Issue 6, 2003, Pages 1053-1062

  Fujiwara, Kenjiro ^a,b   Date, Isao ^a   Shingo, Tetsuro ^a   Yoshida, Hideyuki ^a   Kobayashi, Kazuki ^a   Takeuchi, Akira ^a   Yano, Akimasa ^a   Tamiya, Takashi ^a   Ohmoto, Takashi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Kosei General Hospital   (Japan)

Author keywords

Basic fibroblast growth factor; Cerebral ischemia; Encapsulated graft; Neural transplantation; Rat

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; CELL ENCAPSULATION; CELL LINE; CONTROLLED STUDY; EXPERIMENTAL RAT; NICK END LABELING; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RAT; SECRETORY CELL; STAINING; TRANSPLANTATION; ANIMAL; BRAIN INFARCTION; CELL TRANSPLANTATION; CEREBRAL ARTERY DISEASE; DISEASE MODEL; DRUG EFFECT; DRUG FORMULATION; HAMSTER; MALE; PATHOLOGY; SECRETION; SPRAGUE DAWLEY RAT; XENOGRAFT;

ANIMALS; APOPTOSIS; BRAIN INFARCTION; CELL LINE; CELL TRANSPLANTATION; CRICETINAE; DISEASE MODELS, ANIMAL; DRUG COMPOUNDING; FIBROBLAST GROWTH FACTOR 2; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; RATS; RATS, SPRAGUE-DAWLEY; TRANSPLANTATION, HETEROLOGOUS;

EID: 1342332066     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/jns.2003.99.6.1053     Document Type: Article

References (50)

1. Abe K, Hayashi T, Itoyama Y: Amelioration of brain edema by topical application of glial cell line-derived neurotrophic factor in reperfused rat brain. Neurosci Lett 231:37-40, 1997
2. Aeibisher P, Tresco PA, Winn SR, et al: Long-term cross-species brain transplantation of a polymer encapsulated dopamine-secreting cell line. Exp Neurol 111:269-275, 1991
3. Ay I, Sugimori H, Finklestein SP: Intravenous basic fibroblast growth factor (bFGF) decreases DNA fragmentation and prevents downregulation of Bcl-2 expression in the ischemic brain following middle cerebral artery occlusion in rats. Brain Res Mol Brain Res 87:71-80, 2001
4. Baird A: Potential mechanisms regulating the extracellular activities of basic fibroblast growth factor (FGF-2). Mol Reprod Dev 39:43-48, 1994
5. Belayev L, Alonso OF, Busto R, et al: Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model. Stroke 27:1616-1623, 1996
6. Bethel A, Kirsch JR, Koehler RC, et al: Intravenous basic fibroblast growth factor decreases brain injury resulting from focal ischemia in cats. Stroke 28:609-616, 1997
7. Brightman MW, Reese TS: Junctions between intimately apposed cell membranes in the vertebrate brain. J Cell Biol 40:648-677, 1969
8. Charriaut-Marlangue C, Margill I, Represa A, et al: Apoptosis and necrosis after reversible focal ischemia: an in situ DNA fragmentation analysis. J Cereb Blood Flow Metab 16:186-194, 1996
9. Cserr HF, Cooper DN, Milhorat TH: Flow of cerebral interstitial fluid as indicated by the removal of extracellular markers from the rat caudate nucleus. Exp Eye Res 25 (Suppl):461-473, 1977
10. Cserr HF, Ostrach LH: Bulk flow of interstitial fluid after intracranial injection of Blue Dextran 2000. Exp Neurol 45:50-60, 1974
11. Cuevas P, Carceller F, Ortega S, et al: Hypotensive activity of basic fibroblast growth factor. Science 254:1208-1210, 1991
12. Date I, Ohmoto T: Neural transplantation and trophic factors in Parkinsons disease: special reference to chromaffin cell grafting, NGF support from pretransected peripheral nerve, and encapsulated dopamine-secreting cell grafting. Exp Neurol 137:333-344, 1996
13. Date I, Ohmoto T, Imaoka T, et al: Chromaffin cell survival from both young and old donors is enhanced by co-grafts of polymer-encapsulated human NGF-secreting cells. Neuroreport 7:1813-1818, 1996
14. Date I, Ohmoto T, Imaoka T, et al: Cografting with polymer-encapsulated human nerve growth factor-secreting cells and chromaffin cell survival and behavioral recovery in hemiparkinsonian rats. J Neurosurg 84:1006-1012, 1996
15. Date I, Shingo T, Ohmoto T, et al: Long-term enhanced chromaffin cell survival and behavioral recovery in hemiparkinsonian rats with co-grafting polymer encapsulated human NGF-secreting cells. Exp Neurol 147:10-17, 1997
16. Date I, Shingo T, Yoshida H, et al: Grafting of encapsulated genetically modified cells secreting GDNF into the striatum of parkinsonian model rats. Cell Transplant 10:397-401, 2001
17. Emerich DF, Winn SR, Christenson L, et al: A novel approach to neural transplantation in Parkinson's disease: use of polymer-encapsulated cell therapy. Neurosci Biobehav Rev 16:437-447, 1992
18. Fisher M, Meadows ME, Do T, et al: Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats. J Cereb Blood Flow Metab 15:953-959, 1995
19. Harrigan MR, Ennis SR, Sullivan SE, et al: Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume. Acta Neurochir 145:49-53, 2003
20. Huang Z, Chen K, Huang PL, et al: bFGF ameliorates focal ischemic injury by blood flow-independent mechanisms in eNOS mutant mice. Am J Physiol 272:H1401-H1405, 1997
21. Jiang N, Finklestein SP, Do T, et al: Delayed intravenous administration of basic fibroblast growth factor (bFGF) reduces infarct volume in a model of focal cerebral ischemia/reperfusion in the rat. J Neurol Sci 139:173-179, 1996
22. Kawamata T, Alexis NE, Dietrich WD, et al: Intracisternal basic fibroblast growth factor (bFGF) enhances behavioral recovery following focal cerebral infarction in the rat. J Cereb Blood Flow Metab 16:542-547, 1996
23. Kawamata T, Dietrich WD, Schallert T, et al: Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction. Proc Natl Acad Sci USA 94:8179-8184, 1997
24. Kent TA, Quast M, Taglialatela G, et al: Effect of NGF treatment on outcome measures in a rat model of middle cerebral artery occlusion. J Neurosci Res 55:357-369, 1999
25. Kitagawa H, Hayashi T, Mitsumoto Y, et al: Reduction of ischemic brain injury by topical application of glial cell line-derived neurotrophic factor after permanent middle cerebral artery occlusion in rats. Stroke 29:1417-1422, 1998
26. Kitagawa H, Sasaki C, Sakai K, et al: Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents ischemic brain injury after transient middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 19:1336-1344, 1999
27. Koketsu N, Berlove DJ, Moskowitz MA, et al: Pretreatment with intraventricular basic fibroblast growth factor decreases infarct size following focal cerebral ischemia in rats. Ann Neurol 35:451-457, 1994
28. Kostyk SK, Kourembanas S, Wheeler EL, et al: Basic fibroblast growth factor increases nitric oxide synthase production in bovine endothelial cells. Am J Physiol 269:H1583-H1589, 1995
29. Kurokawa T, Seno M, Igarashi K: Nucleotide sequence of rat basic fibroblast growth factor cDNA. Nucleic Acids Res 16:5201, 1988
30. Levin VA, Fenstermacher JD, Patlak CS: Sucrose and inulin space measurements of cerebral cortex in four mammalian species. Am J Physiol 219:1528-1533, 1970
31. Longa EZ, Weinstein PR, Carlson S, et al: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84-91, 1989
32. Lyons MK, Anderson RE, Meyer FB: Basic fibroblast growth factor promotes in vivo cerebral angiogenesis in chronic forebrain ischemia. Brain Res 558:315-320, 1991
33. Mattson MP, Scheff SW: Endogenous neuroprotection factors and traumatic brain injury: mechanisms of action and implications for therapy. J Neurotrauma 11:3-33, 1994
34. Miyoshi Y, Date I, Ohmoto T, et al: Histological analysis of microencapsulated dopamine-secreting cells in agarose/poly(styrene sulfonic acid) mixed gel xenotransplanted into the brain. Exp Neurol 138:169-175, 1996
35. Nakata N, Kato H, Kogure K: Protective effects of basic fibroblast growth factor against hippocampal neuronal damage following cerebral ischemia in the gerbil. Brain Res 605:354-356, 1993
36. Niwa H, Yamamura K, Miyazaki J: Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193-199, 1991
37. Nozaki K, Finklestein SP, Beal MF: Basic fibroblast growth factor protects against hypoxia-ischemia and NMDA neurotoxicity in neonatal rats. J Cereb Blood Flow Metab 13:221-228, 1993
38. Ono T, Date I, Imaoka T, et al: Evaluation of intracerebral grafting of dopamine-secreting PC12 cells into allogeneic and xenogeneic brain. Cell Transplant 6:511-513, 1997
39. Page LK: Cerebrospinal fluid and extracellular fluid: their relationship to pressure and duration of canine hydrocephalus. Childs Nerv Syst 1:12-17, 1985
40. Puumala M, Anderson RE, Meyer FB: Intraventricular infusion of HBGF-2 promotes cerebral angiogenesis in Wistar rat. Brain Res 534:283-286, 1990
41. Rosenblatt S, Irikura K, Caday CG, et al: Basic fibroblast growth factor dilates rat pial arterioles. J Cereb Blood Flow Metab 14:70-74, 1994
42. Schabitz WR, Li F, Irie K, et al: Synergistic effects of a combination of low-dose basic fibroblast growth factor and citicoline after temporary experimental focal ischemia. Stroke 30:427-432, 1999
43. Shingo T, Date I, Yoshida H, et al: Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson's disease. J Neurosci Res 69:946-954, 2002
44. Tanaka R, Miyasaka Y, Yada K, et al: Basic fibroblast growth factor increases regional cerebral blood flow and reduces infarct size after experimental ischemia in a rat model. Stroke 26:2154-2159, 1995
45. Tatlisumak T, Takano K, Carano RA, et al: Effect of basic fibroblast growth factor on experimental focal ischemia studied by diffusion-weishted and perfusion imaging. Stroke 27:2292-2298, 1996
46. Walicke PA: Basic and acidic fibroblast growth factors have trophic effects on neurons from multiple CNS regions. J Neurosci 8:2618-2627, 1988
47. Yamashita K, Wiessner C, Lindholm D, et al: Post-occlusion treatment with BDNF reduces infarct size in a model of permanent occlusion of the middle cerebral artery in rat. Metab Brain Dis 12:271-280, 1997
48. Yoshida H, Date I, Shingo T, et al: Stereotactic transplantation of a dopamine-producing capsule into the striatum for treatment of Parkinson disease: a preclinical primate study. J Neurosurg 98:874-881, 2003
49. Yukawa H, Takahashi JC, Miyatake SI, et al: Adenoviral gene transfer of basic fibroblast growth factor promotes angiogenesis in rat brain. Gene Therapy 7:942-949, 2000
50. Zhang Y, Pardridge WM: Neuroprotection in transient focal brain ischemia after delayed intravenous administration of brain-derived neurotrophic factor conjugated to a blood-brain barrier drug targeting system. Stroke 32:1378-1384, 2001